As indicated, the frequency of HER2/neu expression was significantly different based on the type of cancer, and higher frequencies of 3+ and 2+ HER2 were observed in adenocarcinoma, whereas all 15 patients with small cell carcinoma had IHC 0 (P < 0.001). This evidence concerns the gene ERBB2 and adenocarcinoma.